Clinical Trial Update: Pediatric Epilepsy Study [Phase 3]

View source ↗

Summary

Novartis-sponsored Phase 3 pediatric epilepsy trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial Epilepsy

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Epilepsy, Epilepsies, Partial | Phase 3 | Status: COMPLETED